United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 1991 HQ Rulings > HQ 0555876 - HQ 0730949 > HQ 0556151

Previous Ruling Next Ruling

HQ 556151

August 15, 1991

CLA-2 CO:R:C:S 556151 SER


TARIFF NO.: 2918.29.5090

Ms. Dorothy Washenko
Import Services Manager
CIBA-GEIGY Corporation
Seven Skyline Drive
Hawthorne, NY 10532-188

RE: Eligibility for duty preference under the U.S.-Canada Free Trade Agreement of an antioxidant/thermal stabilizer; General Notes 3(c)(vii)(A), 3(c)(vii)(B)(1), HTSUSA

Dear Ms. Washenko:

This is in reference to your letter of May 14, 1991, to our New York office, concerning the classification under the Harmonized Tariff Schedule of the United States Annotated (HTSUSA), of Irganox 1076 FF, an antioxidant/thermal stabilizer, from Canada.


CIBA-GEIGY exports "Irganox 1076", which is a U.S.- manufactured antioxidant in powder form, to CIBA-GEIGY Canada to be processed by compaction into granular form, and is returned to the U.S. as "Irganox 1076 FF". Irganox 1076 and Irganox 1076 FF are both composed of Octadecyl 3,5-di-tert-butyl-4- hydrocinnamate, CAS #2082-79-3, and are used interchangeably as an antioxidant and thermal stabilizer in rubber and plastic applications.

The compaction process is a mechanical process in which the powder product (Irganox 1076) is converted into a granular form. The powder is fed into a roller compaction unit, which consists of two cooled cylindrical rollers, where it is compressed between the rollers under high pressure into flakes. The flakes are then reduced in size by a flake breaker and then separated to achieve the final desired granular size. The article, now designated as Irganox 1076 FF, is then imported back into the U.S.

There is no chemical difference between Irganox 1076 and Irganox 1076 FF. In addition, there is no difference in the commercial application of the two products.


Whether the Irganox 1076 FF is eligible for preferential duty treatment under the U.S.- Canada Free Trade Agreement (CFTA).


The implementation of the CFTA is outlined in General Note 3(c)(vii) of the HTSUSA. General Note 3(c)(vii)(A), HTSUSA, provides that "originating goods", as defined in General Note 3(c)(vii)(B), HTSUSA, that are imported into the customs territory of the U.S. and entered under a provision of the HTSUSA for which a rate of duty appears in the "Special" subcolumn followed by the symbol "CA" in parenthesis are eligible for the tariff treatment set forth in the "Special" subcolumn.

General Note 3(c)(vii)(B)(1), HTSUSA, provides that goods from Canada are eligible for preferential treatment as "originating goods" if they are goods wholly obtained or produced in the territory of Canada and/or the U.S. In this case, the Irganox 1076 FF would be considered goods wholly produced in the U.S. and Canada, and, therefore, would be considered an "originating good" for CFTA purposes.

Irganox 1076 FF, as well as Irganox 1076, is properly classified in subheading 2918.29.5090, HTSUSA, which provides for carboxylic acids: other: other, and is designated as "CA" in the "Special" subcolumn with a rate of duty of "Free".


The Irganox 1076 FF, imported from Canada, is properly classified in subheading 2918.29.5090, HTSUSA, which provides for duty-free treatment under the CFTA. As an "originating good", the Irganox 1076 FF is eligible for the preferential duty treatment under this Agreement.


John Durant, Director
Commercial Rulings Division

Previous Ruling Next Ruling